Cadrenal Therapeutics, Inc. (CVKD)

NASDAQ: CVKD · IEX Real-Time Price · USD

0.430

-0.010 (-2.21%)

At close: Jul 19, 2024, 4:00 PM

0.490

+0.060 (13.95%)

Pre-market: Jul 20, 2024, 9:28 AM EDT

Cadrenal Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022
Selling, General & Admin	3.71	3.55	2.31
Research & Development	1.48	4.08	0.39
Other Operating Expenses	0	0	0
Operating Expenses	5.19	7.63	2.7
Operating Income	-5.19	-7.63	-2.7
Interest Expense / Income	0	0.02	0.11
Other Expense / Income	-0.34	0.71	3.91
Pretax Income	-4.85	-8.36	-6.71
Net Income	-4.85	-8.36	-6.71
Shares Outstanding (Basic)	16	13	8
Shares Outstanding (Diluted)	16	13	8
Shares Change	48.61%	70.99%	-
EPS (Basic)	-0.31	-0.62	-0.85
EPS (Diluted)	-0.31	-0.62	-0.85
Free Cash Flow	-3.95	-3.53	-1.21
Free Cash Flow Per Share	-0.25	-0.26	-0.15
EBITDA	-4.84	-8.34	-6.61
Depreciation & Amortization	0	0	0
EBIT	-4.85	-8.34	-6.61

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).